Clinical Trials Search
Phase I/II Study of Post-Cryosurgery (Salvage) Radiotherapy in Carcinoma of the Prostate
94-476
- Eligibility:Click Here to View1.0) Residual tumor in prostate, periprostatic tissue following definitive cryosurg.
2.0) PS 0-2
3.0) No prior pelvic RT
Drug: Not applicable - Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
Colorectal Adenoma Chemoprevention Trial Using Aspirin: A Phase III Study
94-92-51
- Eligibility:Click Here to View1.0) Path (+) colon or rectal cancer.
2.0) Age >30 and 75.
3.0) No current chemo or RT.
4.0) No NSAID use or contraindications to aspirin use.
5.0) No familial polyposis, active\u0009malignancy or inflammatory bowel dz
6.0)
7.0) No immunosuppressive therapy w/in 6 mo. preceeding study entry.
Drug: Aspirin (provided) - Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
Phase III Double-Blind Placebo-Controlled Trial to Assess the Effectiveness of Sucralfate in the Prevention of Treatment-Induced Diarrhea in Patients Receiving Pelvic Radiation Therapy
94-92-52
- Eligibility:Click Here to View
- Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
A Phase II Trial of Preoperative Paclitaxel and Carboplatin in Patients with Resectable Non-Small Cell Lung Cancer
95-24-51
- Eligibility:Click Here to View1.0) Path (+) NSCLC, T1-3, N0-1, MO (hilar node =1.5 cm on CT considered N1 dz)
2.0) Mediastinoscopy required to exclude N2 dz. See protocol
3.0) No serious cardiac problems.
4.0)
5.0) No prior chemo or RT.
6.0)
Drug: Carbo, Taxol (provided) - Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
A Phase II Trial of Edatrexate in Combination With Vinblastine, Adriamycin, Cisplatin, and Filgrastim (EVAC/G-CSF) in Patients With Advanced Non-Small Cell Lung Cancer
95-24-52
- Eligibility:Click Here to View
- Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
Phase III Controlled Evaluation of Glutamine for Decreasing Stomatitis in Patients Receiving 5FU (Fluorouracil) - Based Chemotherapy
95-92-51
- Eligibility:Click Here to View
- Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
A Phase III Trial of Total Androgen Suppression Versus Total Androgen Suppression Plus Definitive External Beam Irradiation for Pathologic Lymph Node Positive (pN+) Adenocarcinoma of the Prostate
96-08
- Eligibility:Click Here to View1.0) Path (+) prostate ca with elevated PSA.
2.0) Path (+) pelvic lymph node involvement.
3.0) No prior chemo or RT.
4.0) No distant mets.
5.0) PSA = 4.0 is mandatory.
6.0) PS = 70 (0-1)
7.0) Orchiectomy if done, must be = 90 days prior to randomization; chemical hormones may be started prior to random. But must begin = 90 days before study entry.
8.0) Negative bone scan and CXR.
Drugs: Zoladex, Lupron Depot, Flutamide - Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
A Phase II Study of Extended Field Radiation Following Therapeutic Para-aortic node Dissection for patients with carcinoma of the Uterine Cervix with Para-aortic Nodal Metastases
96-13
- Eligibility:Click Here to View1.0) No mets outside pelvis except para-aortic mets
2.0) PS = 70
3.0) No prior RT, Chemo, or hysterectomy - Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
A Intermittent, Alternating Chemohormonotherapy Combined with Strontium-89 for Androgen Resistant Metastatic Prostate Carcinoma
96-2
- Eligibility:Click Here to View1.0) Path (+)prostate ca w/ clinical evidence of mets.
2.0) Evidence of hormone unresponsiveness/progres dz despite recent discont. of antiandrogen therapy.
3.0) If no evidence of bi-dimensional msble dz, then PSA must be >20
4.0)
5.0) PS 0-3
6.0) No prior chemo
7.0) Contraindication = 25% RT
Drug: Estramustine, Vinblastine, Adriamycin, Ketoconazole, Strontium-89 - Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.
A Phase II Study of LU 103793 in the Treatment of Advanced Non-Small Cell Lung Cancer
96-24-51
- Eligibility:Click Here to View1.0) Path (+) NSCLC with bidimensionally\u0009measurable dz.
2.0) Stage IIIB or IV NSCLC.
3.0) Arm A - No prior chemo for this dz allowed.
Arm B - Must have received only one previous chemo regimen for this dz and must have ended =4 weeks prior to study entry
4.0) PS 0-2
5.0) Cannot have: RT to >15% of bone marrow/RT =3 weeks.
6.0) Cannot have: CNS mets.
Drugs: LU 103793 (provided).
7.0) - Consent forms:You must be logged in to view the documents.
- Protocols:You must be logged in to view the documents.